Home EASL 2026 | Hepatitis B New Drug GSK836 Phase III Data Published: Can It Optimize Hepatitis B Cure Strategies?

EASL 2026 | Hepatitis B New Drug GSK836 Phase III Data Published: Can It Optimize Hepatitis B Cure Strategies?

May 29, 2026 20:00 CST Updated May 30, 02:40
GSK China

Pharmaceutical Manufacturer